This bill aims to amend and reenact the operational requirements for medication-assisted treatment programs in West Virginia, specifically focusing on the standards for drug testing and the qualifications of medical directors and counseling staff. Key provisions include the requirement for each program to designate a medical director who must hold an active and unencumbered medical license and meet specific training requirements. The bill also stipulates that counseling staff must possess certain qualifications, such as being licensed psychiatrists or certified alcohol and drug counselors.

Significant changes include the introduction of a structured drug testing program, which mandates monthly tests for the first three months of treatment, followed by quarterly tests for the next nine months, and four tests per year thereafter. Additionally, the bill removes previous language regarding Medicaid enrollment requirements and clarifies the responsibilities of prescribers in maintaining control over prescription methods. Other amendments include the requirement for clear documentation in patient files when prescribing higher doses of buprenorphine and the necessity for physicians to consult with obstetrical or gynecological providers when appropriate. Overall, the bill seeks to enhance the regulatory framework governing medication-assisted treatment programs to ensure better compliance and patient care.

Statutes affected:
Introduced Version: 16B-13-5